EB Pharma to Start Hepatitis D Therapy Study with Janssen
News
A subsidiary of Eiger BioPharmaceuticals, Inc., EB Pharma, LLC., has announced the execution of an agreement with Janssen Pharmaceutical NV, focused on the exclusive licensing of tipifarnib, a potential new therapy for the ... Read more